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The use of electricity for analgesic effects has a long history and yet currently 
neuromodulation devices based on electrical stimulation are typically restricted 
to being a last resort intervention for pain patients after the failure of pharmaco-
logical treatments. Whilst spinal cord stimulation is an established intervention 
for intractable neuropathic pain, the use of neuromodulation for other forms of 
pain and targeting different aspects of pain processing is less well established. 
Non-invasive neuromodulation as part of a standard intervention for pain relief 
would be ideal for without long term treatment of a chronic pain condition as it 
would avoid the inevitable side effects associated with long-term use of phar-
macological interventions or interactions between different drug treatments. 
This is particularly relevant as chronic pain can be associated with diseases that 
would require pharmacological treatment for the primary condition. However, 
there is currently both a deficit in understanding the mechanisms of the different 
non-invasive devices and also in how these devices may facilitate pain relief for 
specific conditions. This review will focus on the application of electric currents 
non-invasively to different sites for pain relief and outline the future potential of 
these technologies.
Keywords: pain, electric current stimulation, non-invasive neuromodulation, 
transcutaneous stimulation, tDCS, tACS, ta-VNS
1. What is neuromodulation? Why is pain a challenge?
Neuromodulation has been defined by the International Neuromodulation 
Society (INS) as “the alteration of nerve activity through targeted delivery of 
a stimulus, such as electrical stimulation or chemical agents, to specific neuro-
logical sites in the body” [1, 2]. Neuromodulation has a wide range of possible 
clinical applications from the enhancement of vision, auditory function and 
the control of musculature, but the application to alleviate pain is perhaps one 
of the most challenging for the field. Whilst the efficacy of neuromodulation 
interventions, for instance for movement disorders, can be easily measured due 
to the many ways in which successful movement execution can be characterized, 
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and improvements in vision and audition measured via sensory detection 
thresholds, the efficacy of a potential neuromodulation intervention to alleviate 
pain is far harder to determine. Currently there is not an established biomarker 
for pain, and objective measurement of an individual’s pain levels either before 
or after an intervention is difficult due to the subjectivity inherent in the pain 
experience.
Pain involves multiple processing regions from the periphery through to the 
brain and therefore, successful neuromodulation for pain relief has a number of 
possible targets. A clear premise of clinical neuromodulation is that pathological 
alterations in neuronal function are targeted, but for chronic pain these altera-
tions can occur due to dysfunctions at a number of different sites within the 
multiple interconnected pain processing pathways. Additionally the mechanisms 
underlying the persistence of pain long after the initial injury, and the formation 
of a chronic pain state, still remain elusive. Pain, particularly chronic pain, is 
typically regarded as a human phenomenon, with other animals simply experi-
encing nociception; a stimuli that generates a reflexive response but without key 
aspects that encompass pain; that is without cognitive and emotional evaluative 
aspects.
Neuromodulation, particularly non-invasive neuromodulation, is a rapidly 
emerging field for therapeutic interventions and although the effects of stimulation 
are evident, many questions remain open; what patient groups will this technique be 
effective for?; what stimulation parameters should be used for optimum efficacy?; 
what is the most efficacious target for pain relief? Furthermore the mechanisms 
underlying neuromodulation has not been completely established. Therefore, taken 
together, the design of optimum neuromodulation protocols and targets for pain 
relief is an area that still requires development.
2. Importance of developing neuromodulation for pain relief
Chronic pain is a global health problem with both a high economic cost in 
addition to its substantial detrimental impact on quality of life [3]. Remarkably 
lifetime prevalence of chronic pain has been put as high as 50% of the global 
population [4, 5]. Chronic pain is the most common co-morbidity for a disease, 
with pain as the most frequent reason for seeking healthcare. Recently chronic 
pain has been recognized by the World Health Organization as a disease and 
included in the international classification of diseases (ICD-11) [6]. However, 
treatment interventions are lacking; pharmacological interventions providing 
inadequate pain relief with the mismanagement of opioids well documented as 
both increasing mortality and exacerbating pain. For neuromodulation to be an 
effective alternative for analgesia, an understanding of the mechanisms leading 
to pain conditions and the networks that enhance pain or inhibit pain is essential. 
For therapeutic benefit, neurostimulation techniques should modulate the ner-
vous system in a non-destructive way with reversible effects that can be applied 
long term and have specificity to a targeted network. Further the intervention 
should be controlled dependent on individual patient requirements [7]. Recently 
a number of new non-invasive techniques have emerged; weak electric currents 
applied transcranially to cortical or sub-cortical site are proposed as interven-
tions for a number of diseases that are associated with pathological alterations in 
neuronal excitability [8, 9], including chronic pain. Further the recent develop-
ment of transcutaneous vagal nerve stimulation also offers therapeutic potential 
for some pain patients. Although these novel non-invasive interventions offer 
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promise, there remain areas of uncertainty with regards to how to optimize 
stimulation protocols and standardize their efficacy across individuals.
3.  The anatomical substrates for pain: potential targets for 
neuromodulation
The sensation of acute pain originates from stimulation of nociceptors. 
Nociceptive input has different modalities; thermal, chemical or mechanical; 
that are all capable of causing pain. Receptor types and ion channels will differ 
dependent on the stimulus and intensity, but with free nerve endings transmit-
ting the noxious information to Aδ and C afferents. The TRP channels for trans-
duction of noxious temperature sensation are well characterized [10, 11], with 
less known about mechanical pain [12]. Myelinated, high velocity (20 m/s) Aδ 
fibers and un-myelinated, low velocity (2 m/s) and C fibers transmit nociceptive 
information from the periphery to the dorsal horn. Both Aδ and C afferent fibers 
terminate in the dorsal horn of the spinal cord, where afferent input is organized 
in the rexed laminae; finer diameter fibers terminate more laterally, and larger 
fibers more medially. Large diameter Aβ fibers conveying innocuous touch can 
modulate nociception transmission as formulated by the gate-control theory of 
pain. This theory represented a ground breaking advance in the understand-
ing of the peripheral and spinal processing of nociceptive inputs that led to 
the development of therapeutic neuromodulation interventions [13]. There is 
transmission from the spinal cord via multiple ascending pathways; spinotha-
lamic, spinoreticular, spinomesencephalic, and spinocervical pathways [14]. 
The thalamus is an important site of nociceptive transmission to different brain 
regions known to be involved in pain processing and interpretation. Additionally 
significant modulation of afferent input occurs at the thalamus that has led to 
the region being one of the first supraspinal areas targeted in neuromodulation 
interventions. The multiple cortical and sub-cortical regions of the brain that 
are involved in pain processing and modulation have become known as the pain 
neuromatrix [15], or the pain connectome [16]. Particularly critical to the modu-
lation of pain is the descending pain pathways providing endogenous inhibitory 
control of nociceptive input.
Chronic pain typically is defined as pain that lasts 3-6 months, with the pain 
experienced no longer associated with a tissue injury. Chronic pain can result 
from defects in different sites of the pain processing pathways [17] and is often 
associated with both peripheral and central sensitization [18]. The pain processing 
network is known to be complex and distributed. In the brain, painful stimuli is 
known to lead to activation in diverse brain regions; including the frontal lobe, 
anterior cingulate cortex (ACC), primary motor cortex (M1), primary sensory 
cortex (S1), secondary sensory cortex (S2), insular; hypothalamus; nucleus 
cuneiformis; periaqueductal grey; rostral ventromedial medulla; as observed via 
fMRI studies [19]. The development of chronic pain is thought not just to involve 
neural changes but also alterations in glia [20]. These glial changes are thought to 
partly underlie alterations in pain transmission and the formation of chronic pain 
circuitry. Imaging studies show that chronic pain leads to structural and functional 
changes in multiple brain regions [21]. Chronic pain has also been reported to 
be associated with dysregulation of both the sympathetic and parasympathetic 
nervous systems [22]. Therefore, the potential targets for non-invasive neuro-
modulation for pain relief are diverse and could be within the central or peripheral 
nervous systems.
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3.1 Primary motor cortex
Electrical stimulation of the primary motor cortex (M1) is long established as 
an effective treatment for pain. Originally this intervention was limited to invasive 
epidural electrode implantation, and so associated with the risk of surgery [23]. 
More recently non-invasive cortical stimulation has emerged as an interesting, 
effective, and promising modality in the investigation of novel approaches for pain 
relief [24]. The motor cortex represents a cortical region with high intra-cortical 
connectivity as well as connectivity to sub-cortical regions. There are a number of 
explanations for the efficacy of M1 stimulation [25]. M1- thalamic connectivity 
is thought to be particularly significant in neuromodulation effects [26]. Efficacy 
of M1 neuromodulation is also proposed to be due to inhibitory effects via the 
limbic, cortical and subcortical brain areas involved in descending modulatory pain 
control. Further M1 tDCS has been shown to reduce secondary hyperalgesia and 
enhances descending modulatory control [27].
3.1.1 Monitoring the efficacy of M1 stimulation
The measurement of pain in a clinical setting has been typically through visual 
analogue scales (VAS) and numerical rating scales (NRS). However many studies now 
include pain threshold testing via standardized quantitative sensory testing (QST) 
which involves testing across different modalities of nociceptive stimuli so that a pain 
modulation profile can be monitored pre and post treatment intervention [28]. MRI 
studies have examined resting-state functional connectivity alterations in pain patients 
before and after intervention with tDCS and found alterations in connectivity within 
pain processing areas that correlate with a reduction in pain in these patients [29].
Neurophysiological techniques have also been used to monitor changes in corti-
cal excitability after the application of electric currents so that these changes may 
be correlated with pain measures. Increased excitability of the corticospinal tract 
(CST) as measured by the standard neurophysiological technique of motor evoked 
potentials (MEPs) have shown that increased CST excitability is associated with 
analgesic effects [30] and beneficial outcomes for patients [31]. Other neurophysi-
ological measures that have been shown to have value include intracortical disinhi-
bition. A number of studies have observed that there is a reduction in intracortical 
inhibition and an increase in intracortical facilitation, suggesting that motor cortex 
inhibition is dysregulated in chronic pain patients [32] and so providing a neuro-
physiological basis for monitoring efficacy of neuromodulation protocols.
3.2 Endogenous descending control of pain
It is well known that once a nociceptive stimuli has been identified, the typical 
response across all animals is rapid reflexive movement away from the source of the 
noxious stimulus combined with an autonomic response which acts to optimize the 
animal’s ability to escape from threats. The periaqueductal gray (PAG) has a critical 
role in the response to threatening stimuli, both aversion and the autonomic response 
[33, 34]. The PAG is also a key component of the endogenous descending pain path-
way [35]. It receives nociceptive input from spinal, subcortical and cortical inputs, 
and projects to the rostral ventromedial medulla (RVM) and also to cortical areas 
and the spinal cord. The initial rodent studies of PAG stimulation demonstrated a 
large analgesic effect subsequent to stimulation [36]. Subsequently, PAG stimula-
tion has shown anti-nociceptive effects from rodents to man and is now known as 
an essential circuit for opioid based analgesia. However, it is also established that 
the PAG and descending pathways play a complex role in pain and can facilitate as 
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well as inhibit pain. Importantly, these endogenous descending pain pathways are 
thought to be defective in some patients, leading to chronic pain. To improve and 
develop neuromodulatory interventions it would be ideal to first characterize the 
integrity of the patient’s descending modulatory pathway and subsequently monitor 
the effect of an intervention on this pathway. Two experimental observations using 
psychophysical methods are thought to enable important insights in the endogenous 
descending modulatory control and have generated interest in pain research. These 
are offset analgesia (OA) [37] and conditioned pain modulation (CPM) [38]. It 
would be useful if these methods could monitor the efficacy of neurostimulation 
protocols aimed at enhancing inhibitory pain pathways.
3.2.1 Offset analgesia
Offset analgesia (OA) is a phenomenon observed in both experimental and 
clinical studies [39]. OA is defined as a disproportionate reduction in pain after a very 
slight decrease in experimental pain stimulus intensity. The size of the OA effect is 
very large, with the effect thought to be over 250% when compared with equivalent 
increases in pain intensity [39].
The physiological mechanism and function of this phenomenon is not completely 
understood, but there is substantial interest in OA due to the apparent analgesia that 
it can convey in the presence of a previously painful heat stimulus. Additionally defi-
cits in OA has been demonstrated in a number of different clinical group of chronic 
pain patients, and therefore a psychophysical OA protocol could be incorporated as 
part of a diagnostic protocol for chronic pain patients [40]. However, there is debate 
over whether OA could be used as a means to monitor the success of pharmacological 
interventions [41, 42] and suggests that this protocol requires reliability testing prior 
to use for the assessment of intervention efficacy. fMRI evidence has suggested that 
the PAG is activated during OA suggesting that the descending control pain pathway 
is important in the experience of this phenomenon [43].
3.2.2 Conditioned pain modulation
Conditioned pain modulation (CPM) represents the phenomenon of ‘pain 
inhibits pain’ and is thought to be the human counterpart to descending noxious 
inhibitory control (DNIC) that has strong electrophysiological evidence in rodent 
pain models [44]. Although DNIC was observed in rats in the 1970s, the human 
counterpart as observed through psychophysical methods is much more recent [38]. 
While there is increasing evidence that deficits in CPM can predict the development 
of chronic pain the reliability of the response has been questioned and there are a 
number of alternative protocols in the literature [38].
Patients with knee osteoarthritis have also been found to have defects in the 
descending pain control that can be characterized by defects in CPM. Further CPM 
paradigms have been used to monitor the effect of neuromodulation interventions on 
the endogenous inhibitory pathways in experimental pain in healthy participants [45] 
and clinical pain in Fibromyalgia patients [46]. As well as M1 stimulation influencing 
descending pain pathways it is possible that prefrontal stimulation may also modulate 
PAG due to the known connectivity [47]. Prefrontal tDCS is a common target for tDCS 
for pain modulation [25, 48], but not currently assessed in the context of descending 
pain pathways as monitored via CPM protocols. However patient studies using tDCS 
of the left dorsolateral prefrontal cortex have suggested efficacy is achieved via 
enhancement of descending pain modulation as well as known cognitive effects of 
this stimulation [49]. The link between PAG and cerebellar circuitry [50] may sug-
gest that cerebellar tDCS could also influence PAG. Experimental pain studies have 
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explored the use of cerebellar tDCS as a target for modulating pain thresholds [51], 
but there are currently only a few studies.
3.3 Vagal nerve stimulation
The vagus nerve is a large tract originating at the brainstem and is known for its 
widespread innervation, targeting every major thoracic and abdominal organ [52, 53]. 
Vagal nerve stimulation (VNS) has similarly been shown to provide multi-systems 
effects, and thus useful for a wide range of disease interventions. The recent develop-
ment of non-invasive vagal nerve stimulation; via transcutaneous auricular vagus 
nerve stimulation (ta-VNS); rather than the traditional cervical implantation; increases 
therapeutic potential of the intervention as it removes the need for surgery [54]. 
Due to the novelty of ta-VNS there is currently a lack of consensus over the optimal 
stimulation protocol [55]. Stimulation is typically of low amplitude current (~5 mA) 
with pulses of 250–500 μs with a frequency of between 10 and 25 Hz [54]. Recently 
a number of studies have made efforts to individualize the stimulation level based on 
perceptual threshold using sequential testing protocols.
There is increasing evidence that VNS has anti-nociceptive effects [56, 57]. 
Analgesia is thought to occur through both the inhibition of spinal nociceptive 
reflexes and ascending transmission. There is evidence VNS and ta-VNS also 
modulates ascending inputs in the brain by altered activity in pain processing 
regions as observed via fMRI [55, 58]. Further a recent study examined the brain-
stem fMRI response to a respiratory gated ta-VNS protocol (known as RAVANS). 
Interestingly this study found that stimulation led to greater blood oxygen level 
dependent (BOLD) responses in the PAG [59]. Further this study explored the use 
of different stimulation frequencies, with a frequency of 100 Hz showing increased 
responsiveness of PAG. This alteration to a key site for endogenous pain modula-
tion provides additional support for the potential of VNS for pain relief. Opioid 
receptor antagonists are found to reduce the efficacy of VNS, indicating that there 
is an opioid based mechanism for analgesia. Further VNS is also widely thought to 
have anti-inflammatory effects [56]. These anti-inflammatory effects are proposed 
to be due to neural-immune interaction at the peripheral nerves [60], with electric 
stimulation of the vagus nerve triggering a neural-immune reflex via cholinergic 
anti-inflammatory pathways that dampen the inflammatory response to infection 
or tissue injury and suppress the release of pro-inflammatory cytokines.
4. Translation for patient pain relief ?
Early studies using tDCS in patient studies have had variable success and lack 
strong evidence of treatment efficacy [61]. Initial randomized controlled trials 
of anodal tDCS to primary motor cortex (M1) as an intervention for neuropathic 
pain found the intervention to be ineffective [62]. However, recent studies provide 
support for tDCS of M1 as a treatment intervention for knee osteoarthritis [63], 
fibromyalgia [64] and inflammatory bowel disease [29]. There have also been 
randomized clinical trials using prefrontal tDCS demonstrating tDCS to be effec-
tive in pain reduction in patients with multiple sclerosis [65] and fibromyalgia [49] 
and also reduce post-surgical opioid use [66]. A recent meta-analysis of selected 
randomized controlled trials of tDCS for non-cancer pain included predominantly 
M1 tDCS but also left dorsolateral prefrontal tDCS [48]. The meta-analysis showed 
active stimulation was consistently better than sham stimulation with stronger evi-
dence for the efficacy of anodal M1 tDCS [48]. However, overall there remain short-
comings in the current literature on tDCS in patient groups; the study numbers are 
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small; the tDCS protocols differ across studies; the patient groups are heterogeneous 
making meta-analysis challenging; and the study designs used inconsistent, with 
some studies favoring a cross-over design to a control group. For tDCS to become an 
established treatment intervention, large multi-centre randomized controlled trials 
with standardized protocols and patient cohorts are necessary.
Studies using VNS in patient groups report beneficial effects of this form of stimu-
lation in patients with pain associated with inflammatory conditions, for instance 
rheumatoid arthritis or migraine. Indeed recent studies have provided strong support 
for the use of vagal nerve stimulation in arthritis patients [56]. The combination 
of anti-inflammatory effects of VNS [67] with the previously mentioned analgesic 
effects via the endogenous opioid system may explain the potential for this technique 
in these patient groups. In fibromyalgia, although the disease etiology is uncertain, 
patients are known to experience systemic inflammation and neuroinflammation, 
and so may be a patient group that particularly benefits from this intervention.
5.  Methodology for translation of electric current stimulation to the 
clinic
Evidence for the efficacy of non-invasive application of electric currents in 
humans for neuromodulatory effects has been rapidly increasing, with many pro-
posed applications, including pain. The potential applications explored have been 
extensive as the technique is easy to implement, cheap and well tolerated by partici-
pants. Additionally an interesting potential development of non-invasive neuro-
modulation interventions suggests the method is a viable technique for patients to 
use in their homes with remote monitoring [68]. However there is not currently a 
consensus on the optimal protocols and variability in effects across individuals have 
been widely reported. For translation to the clinic, systematic study into the effect 
of altering the amplitude and duration of the applied electrical current is essential. 
These parameters include; electrode montage when targeting a given area; size of 
the electrodes; magnitude of stimulation and duration of stimulation [69]. As with 
many therapeutic interventions key questions are; how can neurostimulation dose 
be determined?; how can treatment fidelity be ensured?; how can individual vari-
ability be controlled when determining dose?
5.1 Electrode montage in tDCS
In tDCS the stimulation electrodes are typically two saline soaked sponge elec-
trodes; an anode and a cathode; that range from 25 to 35 cm2 placed above the region 
of interest and the reference electrode is positioned at another cortical region [70]. 
Early studies with tDCS used a very simple electrode montage, with two electrodes of 
the same size often with the assumption that the effect of the active electrode would be 
independent of the placement and size of the second, reference electrode. For motor 
cortex stimulation the typical electrode montage is to have the reference electrode 
placed over the contralateral orbit. It has been suggested that anodal stimulation 
protocols can be optimized by having the cathodal reference electrode as a larger size, 
thus rendering it functionally inert [71]. Another montage option has been the selec-
tion of an extracephalic reference electrode; typically the deltoid or buccinator muscles. 
Regardless of site used the montage of the two electrodes will inevitably impact on the 
regions where brain modulation will occur due to stimulation. Further the different 
forms of electrodes now available will also influence the applied stimulation as it is 
known that the electrode-skin interface has variable impedance that will be depen-
dent on a number of factors that lead to variability in the delivered current. Modern 
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stimulators are current controlled, but some earlier studies are voltage controlled lead-
ing to the current that reaches the scalp being dependent on differences in impedance 
thus leading to greater variability and difficulty in making comparisons across studies.
5.2 Modeling current flow in tDCS
One limitation of tDCS is that the sites of stimulation are typically identified 
based on the cranial landmarks of the 10-20 system for EEG electrode placement. 
However individual differences in brain anatomy will result in electrode place-
ment that may not correspond exactly to the intended target site of stimulation. 
M1 stimulation can be improved by identifying the individual’s motor hotspot via 
transcranial magnetic stimulation (TMS) before electrode placement, but cur-
rently this is not typically included in the protocols for tDCS studies for pain relief. 
Recently current flow diagrams have been developed and are regarded as critical 
to the optimal administration of tDCS [72]. Ideally these predictions of the cur-
rent flow are adapted to the specific anatomy as recorded via magnetic resonance 
imaging (MRI). Implementing tDCS in this way may help to control for some of 
the observed inconsistency in the effects of tDCS across populations [73]. This may 
be particularly important in some patient populations; recent work has further 
suggested that brain atrophy may also impact of the flow of current [74]. Given the 
observation of structural changes in the brain of chronic pain patients this may be 
problematic [22]. This may to some extent be ameliorated by individualized electric 
field models that can optimize tDCS dosage for patients [75, 76]. Current flow 
modeling also enables tailoring the dose to electrodes of different sizes, including 
high-definition transcranial direct stimulation protocols with smaller electrodes 
arranged in more complex montages to facilitate more focused effects [77, 78]. 
Additionally the current flow modeling may be able to facilitate the use of non-
invasive neurostimulation techniques to deeper brain structures [77], so that novel 
targets in the pain neuromatrix could be stimulated.
5.3 What is the optimum magnitude of the applied electric current?
The effects of electric stimulation of the brain have long been studied in animal 
models [79, 80]. When applied to the brain, the current is thought to alter underly-
ing neuronal excitability but is also thought to affect functionally connected distant 
cortical and sub-cortical regions. However many animal studies apply direct current 
stimulation onto the cortical area (DCS). Therefore the current reaching the cortex 
is typically much greater than with transcranial application. The magnitude of elec-
tric current may be critical for the observed effects so the two methodologies could 
differ substantially. Similarly the trans-cutaneous application of electric currents to 
nerves is also emerging as a useful non-invasive intervention, and again the existing 
animal and human studies are often based on observations from invasive methods.
tDCS and tACS studies typically apply low currents (typically 1–3 mA) with 
1.5–2 mA being the most usual stimulation levels. Recent studies have experimented 
with the use of higher currents (up to 4 mA) [81]. Studies have varied substantially 
in the protocols used, but all would lead to charge densities that would be far lower 
than that required to elicit an action potential. The charge density used in a study 
varies dependent on the size of the electrodes used, and is calculated by the size 
of the electrical current applied divided by the electrode area. The duration of the 
applied electrical stimulation has also been variable across studies but is typically 
within the range of 10–30 minutes. To enhance intervention comparisons studies 
could compare the total charge administered over stimulation period, so taking into 
account the duration electrical stimulation is applied in the intervention period. 
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Future work exploring the appropriate current, as well as how this can be adjusted 
for different individuals is essential. It already known that lower currents are suf-
ficient to lead to membrane polarization and have potential therapeutic benefits. 
Indeed the lower stimulation levels applied to primary motor cortex were in fact 
more effective in increasing motor cortical excitability [82], and may avoid the 
problematic finding of non-linear tDCS effects that have recently been reported 
when increasing current, with a reversal of effects observed in the mid-range of 
applied current (2 mA) [83]. This observation has been paralleled in animal models 
but pharmacological studies are required to discern the effect of the current on 
specific ion channels. Since it has been reported that there is non-linear effect in the 
stimulation magnitude, individual differences in cortical excitability; determined 
by differences in motor evoked potentials when primary motor cortex is the target; 
could become critical for appropriately setting therapeutic dose.
A further tDCS effect that has not undergone much investigation and yet is 
important for implementation in a patient population is the duration of any tDCS 
therapeutic effects, and the impact of protocols involving repetitive stimulation 
is applied. Recent research has explored the short and long stimulation durations 
and compared these with those where short duration protocols are repeated with 
intervals. There is some evidence that repeated stimulation is more efficacious than 
continual longer duration stimulation protocols [84].
5.4 Interaction with individual patient characteristics
There are multiple parameters that can be altered in the administration of tDCS 
stimulation [48]. There will also be alterations of the effect of tDCS due to differing 
characteristics of the patient. There will be environmental factors that will impact on 
tDCS effects that could include the patient’s current cognitive state and fatigue levels. 
Increasingly studies have explored the interaction between tDCS and pharmacologi-
cal interventions, but it must also be considered that other medications taken by the 
participant could impact on the effect of neurostimulation. Many of the conditions 
that tDCS has been proposed to treat would mean that the patient would be taking 
medication [85]. This is particularly critical when considering the use of tDCS for 
pain relief, as chronic pain is a frequent comorbidity. Hormonal influences have been 
suggested to impact both on the perception of pain but also on the effects of tDCS. The 
effect of the interaction of tDCS with estrogen has only recently been explored [86]. 
This is particularly important when considering pain interventions as many conditions 
associated with chronic pain have a higher prevalence in women than men.
5.5 Mechanisms of tDCS
The effect of tDCS has been shown to be polarity-dependent [87]. Application 
of the anodal electrode (a-tDCS) over the target area increases neuronal excitability 
whereas a cathodal electrode (c-tDCS) decreases neuronal excitability [70, 88]. The 
underlying mechanisms of tDCS effects are unclear but tDCS is thought to alter 
neuronal membrane potential and so impact on the action potential threshold [89]. 
These studies suggest that anodal stimulation induced neuronal excitability results 
from neuronal membrane subthreshold depolarization and cathodal inhibitory 
effects are produced by membrane hyperpolarization. It was originally proposed that 
the polarization was from the somatic membrane where there is a higher density of 
sodium channels. Following from this, the short term effect of tDCS have been sug-
gested to be related to increasing permeability to sodium. Additionally the neuronal 
excitability that occurs during anodal tDCS can be removed by pharmacologically 
inhibiting calcium channels and voltage-dependent sodium channels [90].
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Human spectroscopy studies have demonstrated that anodal tDCS causes a 
local gamma aminobutyric acid (GABA) reduction [91] whereas cathodal stimula-
tion leads to decreased glutamatergic neuronal activity. Currently the suggested 
mechanism of tDCS is thought to include presynaptic modulation of neurons, with 
the stimulation effects related to synaptic inputs rather than solely action potential 
generation [92, 93]. Evidence from animal studies of DCS also suggests presynaptic 
effects, with cathodal stimulation reducing the probability of glutamate release and 
anodal stimulation increasing glutamate release probability.
To explain the longer term effects of tDCS, anodal tDCS had been initially 
assumed to induce long term potentiation (LTP)-like effects whereas cathodal tDCS 
thought to induce long term depression (LDP)-like effects. However this is now 
thought to be overly simplistic. Some of the variability in effects of anodal and cath-
odal stimulation has been explained by mechanisms of homeostatic plasticity [94] 
formalized in the Bienenstock-Cooper-Munro (BCM) rule of bidirectional synaptic 
plasticity [95]. These mechanisms are proposed to occur within neural networks to 
prevent hyperactivity or hypoactivity [95].
Importantly recently it has also been highlighted that polarization of the cell 
membrane must be dependent on the orientation of the neuron to the extracellular 
current vector [96]. Further evidence of the importance of axonal orientation has 
been provided by animal studies with evidence from rat hippocampus suggests that 
effects of electrical current vary dependent on the orientation of axons [97]. The 
significance of axonal orientation in the effects of DCS could have wider implica-
tions as to how develop tDCS methods. Diffusion magnetic resonance imaging 
(dMRI) enables an assessment of the structural connectivity and integrity of tracts. 
It has been suggested that tractography achieved from dMRI may be beneficial for 
optimal electrode positioning in clinical instances where there has been disruption 
in fibre tracts due to disease [98] or that dMRI may aid understanding of the effects 
of neuromodulation at a cellular level [99]. Imaging techniques may also offer a 
means of individualizing interventions, but they would have the disadvantage of a 
substantial cost increase for an otherwise cheap intervention.
5.6 tACS
Transcranial alternating current (tACS) of the primary motor cortex (M1) has 
been shown in the past to be effective in modulating sensory thresholds for tactile 
sensation and visual phenomena [100] and offers potential for pain modulation 
[101]. tACS involves weak alternating currents being applied through the skull via 
electrodes on the scalp with montages similar to those used with tDCS. tACS can be 
applied in a wide frequency range, with the effect of each frequency range still to be 
explored. There is evidence of gamma and alpha oscillations being associated with 
pain processing and perception. Despite its potential only a limited number of studies 
have used tACS although alpha range stimulation has been found beneficial for 
pain relief [102]. Studies combining tACS with fMRI, neurophysiology or QST may 
help address the optimum tACS frequency for pain relief. The mechanistic effects 
of tACS are less well understood than tDCS and interestingly there has been the 
suggestion that tACS effects could be a result of stimulation of peripheral nerves 
trans-cutaneously rather than effects on cortical neurons [103].
5.7 Less explored effects of electric currents and future research avenues
Imposed electric fields may have a wider biological effects. For instance tDCS 
could influence glia [89, 104]. Future work should consider these largely unex-
plored effects so as to provide a more comprehensive mechanistic basis for weak 
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electric currents dependent on targeted pain processing region. Further some 
consequences of weak electric currents are not widely monitored. Recent studies 
have begun to explore the possible consequences of tDCS on immune responses, 
which is particularly relevant when considering tDCS and ta-VNS for analgesia. 
However, thus far this has been in animal models [105, 106]. Imaging techniques 
such as proton magnetic resonance spectroscopy (H-MRS) could provide a useful 
methodology for monitoring changes in metabolites in response to patient tDCS 
or ta-VNS interventions. For instance, choline and myo-inositol are thought to be 
altered in chronic pain patients and are associated with neuroinflammation [21].
6. Conclusion
Pain is a complex sensation associated with the activity of multiple cortical 
and sub-cortical regions in the brain. The overall pain percept must result from 
the interplay between multiple ascending pathways that convey nociceptive input 
from the peripheral with descending pathways that act to modulate nociceptive 
input. The mechanisms for the formation of chronic pain are uncertain; though 
it is known that there are both peripheral, spinal cord and central mechanisms 
underlying the formation of chronic pain. Non-invasive neuromodulation through 
tDCS presents a particularly interesting treatment intervention for pain as recent 
evidence also suggests that its mechanism of action is not only the modulation 
of neuronal activity but that the technique also influences the neuro-immune 
response. However, for appropriate translation of tDCS to a clinical setting there 
remains the need for research for both increased mechanistic understanding as well 
as studies how the level of electric stimulation applied can be accurately targeted 
and tailored to individuals and different disease groups.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
12
Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice
[1] International Neuromodulation 
Society. International Neuromodulation 
Society Webpage. 2017. Available from: 
http://www.neuromodulation.com/
[2] Krames ES, Rezai AR, Peckham PH. 
Defining neuromodulation. In: 
Krames ES, Rezai AR, Peckham PH, 
editors. Neuromodulation. 
Comprehensive Tectbook of Principles, 
Technologies, and Therapies. Vol. 1. 
London: Academic Press; 2018. pp. 1-13
[3] Eccleston C, Wells C, Morlion B. 
European Pain Management. Oxford: 
Oxford University Press; 2018
[4] Breivik H, Collett B, Ventafrida V, 
Cohen R, Gallacher D. Survey or chronic 
pain in Europe: Prevalence, impact 
on daily life and treatment. European 
Journal of Pain. 2006;10(4):287-333
[5] Harstall C, Ospina M. How prevalent 
is chronic pain? PAIN: Clinical Updates. 
2003;11:1-4
[6] Treede RD et al. A classification 
of chronic pain for ICD-11. Pain. 
2015;156(6):1003-1007
[7] Deer TR, Jain S, Hunter C, 
Chakravarthy K. Neurostimulation for 
intractable chronic pain. Brain Sciences. 
2019;9(23):1-20
[8] To WT, De Ridder D, Hart J, 
Vanneste S. Changing brain networks 
through non-invasive neuromodulation. 
Frontiers in Human Neuroscience. 
2018;12:128
[9] Zaghi S et al. Inhibition of 
motor cortex excitability with 15 
Hz transcranial alternating current 
stimulation (tACS). Neuroscience 
Letters. 2010;479:211-214
[10] Cortright DN, Krause JE, 
Broom DC. TRP channels and pain. 
Biochimica et Biophysica Acta. 
2007;1772:978-988
[11] Jardin I et al. TRPs in pain 
sensation. Frontiers in Physiology. 
2017;8(392):1-10
[12] Piers C, Seal RP. Neural circuits 
for pain: Recent advances and current 
views. Science. 2016;354(6312):578-584
[13] Melzack R, Wall PD. Pain 
mechanisms: A new theory. Science. 
1965;150(3699):971-979
[14] Almeida QF, Frank JS, Roy EA, 
Jenkins ME, Spaulding S, Patla AE. An 
evaluation of sensorimotor integration 
during locomotion toward a target 
in Parkinson’s disease. Neuroscience. 
2005;134(1):283-293
[15] Melzack R. From the gate to the 
neuromatrix. Pain. 1999;(suppl 6)
[16] Kucyi A, Davies KD. The 
dynamic pain connectome. Trends in 
Neurosciences. 2015;38(2):86-95
[17] Kuner R. Central mechanisms of 
pathological pain. Nature Medicine. 
2010;16(11):1258-1266
[18] Costigan M, Scholz J, Woolf CJ. 
Neuropathic pain: A maladaptive 
response of the nervous system 
to damage. Annual Review of 
Neuroscience. 2009;32:1-32
[19] Tracy LM, Ioannou L, Baker KS, 
Gibson SJ, Georgiou-Karistianis N, 
Giummarra MJ. Meta-analytic 
evidence for decreased heart rate 
variability in chronic pain implicating 
parasympathetic nervous system 
dysregulation. Pain. 2016;157(1):7-29
[20] Tracey I, Mantyth PW. The cerebral 
signature for pain perception and its 
modulation. Neuron. 2007;55:377-391
[21] Jung C et al. Magnetic resonance 
imaging of neuroinflammation in 




From Mechanisms to Analgesia: Towards the Use of Non-Invasive Neuromodulation for Pain…
DOI: http://dx.doi.org/10.5772/intechopen.93277
[22] Kuchinad A, Schweinhardt P, 
Seminowicz DA, Wood PB, Chizh BA, 
Bushnell MC. Accelerated brain gray 
matter loss in fibromyalgia patients: 
Premature aging of the brain? Journal of 
Neuroscience. 2007;27(15):4004-4007
[23] Monsalve GA. Motor cortex 
stimulation for facial chronic 
neuropathic pain: A review of 
the literature. Surgical Neurology 
International. 2012;3:S290-S311
[24] Zaghi S, Heine N, Fregni F. Brain 
stimulation for the treatment of pain: 
A review of costs, clinical effects and 
mechanisms of treatment for three 
different central neuromodulatory 
approaches. Journal of Pain 
Management. 2009;2:339-352
[25] Witney AG. Neurostimulation 
techniques for the modulation 
of pain. In: Ustohal L, editor. 
Transcranial Magnetic Stimulation in 
Neuropsychiatry. London: Intech Open; 
2018. pp. 103-121
[26] Polania R, Paulus W, Nitsche MA.  
Modulating cortico-striatal and 
thalamo-cortical functional 
connectivity with transcanial direct 
current stimulation. Human Brain 
Mapping. 2012;33:2499-2508
[27] Meeker TJ, Keaser ML, Khan SA,  
Gullapalli RP, Seminowicz DA, 
Greenspan JD. Non-invasive motor 
cortex neuromodulation reduces 
secondary hyperalgesia and enhances 
activation of the descending pain 
modulatory network. Frontiers in 
Neuroscience. 2019;13(467):1-18
[28] Giannoni-Luza S et al. Non-invasive 
motor cortex stimulation effects on 
quantitative sensory testing (QST) in 
healthy and chronic pain subjects: A 
systematic review and meta-analysis. 
Pain. 2020. (In Press)
[29] Neeb L et al. Transcranial direct 
current stimulation in inflammatory 
bowel disease patients modifies resting-
state functional connectivity: A RCT. 
Brain Stimulation. 2019;12(4):978-980
[30] Moloney TM, Witney AG. 
Pressure pain thresholds increase 
after preconditioning 1 Hz repetitive 
transcranial magnetic stimulation with 
transcranial direct current stimulation. 
PLoS One. 2014;9:e92540
[31] Granovsky Y, Sprecher E, Sinai A. 
Motor corticospinal excitability: A novel 
facet of pain modulation? PAIN Reports. 
2019;4(e725):1-7
[32] Thibaut A, Zeng D, Caumo W, Liu J, 
Fregni F. Corticospinal excitability as a 
biomarker of myofascial pain syndrome. 
PAIN Reports. 2017;2(e594):1-8
[33] Faull OK, Subramanian HH, 
Ezra M, Pattinson KTS. The midbrain 
periaqueductal gray as an integrative 
and interoceptive neural structure 
for breathing. Neuroscience 
& Biobehavioral Reviews. 
2019;98:135-144
[34] Faull OK, Jenkinson M, Ezra M, 
Pattinson KTS. Conditioned respiratory 
threat in the subdivisions of the 
human periaqueductal gray. eLife. 
2016;5:e12047
[35] Ossipov MH. The perception 
and endogenous modulation of pain. 
Scientifica (Cairo). 2012;561761:1-25
[36] Reynolds DV. Surgery in the rate 
during electrial analgesia induced 
by focal brain stimulation. Science. 
1969;164:3878
[37] Nilsson M, Nissen TD, Graversen C, 
Gazerani P, Drewes AM, Brock C. Offset 
analgesia: A reproducibility study. 
Scandinavian Journal of Pain. 
2012;3:192
[38] Kennedy DL, Kemp HI, Ridout D, 
Yarnitsky D, Rice ASC. Reliability 
of conditioned pain modulation: 
Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice
14
A systematic review. Pain. 
2016;157(11):2410-2419
[39] Grill JD, Coghill RC. Transient 
analgesia evoked by noxious stimulus 
offset. Journal of Neurophysiology. 
2002;87:2205-2208
[40] Oudejans LCJ, Smit JH, van 
Velzen M, Dahan A, Niesters M. The 
influence of offset analgesia on the 
onset and offset of pain in patients with 
fibromyalgia. Pain. 2015;156:2521-2527
[41] Niesters M, Hoitsma E, Sarton E, 
Aarts L, Dahan A. Offset analgesia in 
neuropathic pain patients and effect of 
treatment with morphine and ketamine. 
Anesthesiology. 2011;115:1063-1071
[42] Olesen AE et al. Offset analgesia and 
the impact of treatment with oxycodone 
and venlafaxine: A placebo-controlled, 
randomized trial in healthy volunteers. 
Basic & Clinical Pharmacology & 
Toxicology. 2018;123(6):727-731
[43] Derbyshire SWG, Osborn J. Offset 
analgesia is mediated by activation in 
the region of the periaqueductal grey 
and rostral ventromedial medulla. 
NeuroImage. 2009;47:1002-1006
[44] Le Bars D, Dickenson AH, 
Besson JM. Diffuse noxious inhibitory 
controls (DNIC) 1 effects on dorsal horn 
convergent neurones in the rat. Pain. 
1979;6:283-304
[45] Serrano GB et al. Comparison of 
hypnotic suggestion and transcranial 
direct-current stimulation effects on 
pain perception and the descending 
pain modulating system: A crossover 
randomized clinical trial. Frontiers in 
Neuroscience. 2019;13:662
[46] Castelo-Branco L et al. Optimised 
transcranial direct current stimulation 
(tDCS) for fibromyalgia-targeting 
the endogenous pain control system: 
A randomized, double-blind factorial 
clinical trial protocol. BMJ Open. 
2019;9(10):e032710
[47] Ong W-Y, Stohler CS, Herr DR. 
Role of the prefrontal cortex in pain 
processing. Molecular Neurobiology. 
2018;56:1137-1166
[48] Zortea M et al. Transcranial 
direct current stimulation to improve 
the dysfunction of descending pain 
modulatory system related to opioids in 
chronic non-cancer pain: An integrative 
review of neurobiology and meta-
analysis. Frontiers in Neuroscience. 
2019;13:1218
[49] Silva AF et al. Anodal transcranial 
direct current stimulation over the left 
dorsolateral prefrontal cortex modulates 
attention and pain in fibromyalgia: 
Randomized clinical trial. Scientific 
Reports. 2017;7:135
[50] Koutsikou S et al. Neural 
substrates underlying fear-evoked 
freezing: The periaqueductal grey-
cerebellar link. Journal of Physiology. 
2014;592:2197-2213
[51] Bocci T et al. Cerebellar direct 
current stimulation modulates pain 
perception in humans. Restorative 
Neurology and Neuroscience. 
2015;33:597-609
[52] Johnson RL, Wilson CG. A review of 
vagus nerve stimulation as a therapeutic 
intervention. Journal of Inflammation 
Research. 2018;11:203-213
[53] Vonck KEJ, Larsen LE. Vagus 
nerve stimulation: Mechanisms of 
action. In: Krames ES, Peckham PH, 
Rezai AR, editors. Neuromodulation. 
Comprehensive Textbook of Principles, 
Technologies, and Therapies. Vol. 1. 
London: Academic Press; 2018. pp. 
211-220
[54] Badran BW et al. Laboratory 
administration of transcutaneous 
15
From Mechanisms to Analgesia: Towards the Use of Non-Invasive Neuromodulation for Pain…
DOI: http://dx.doi.org/10.5772/intechopen.93277
auricular vagus nerve stimulation 
(taVNS): Technique, targeting and 
considerations. Journal of Visualized 
Experiments. 2020;143
[55] Badran BW et al. Neurophysiologic 
effects of transcutaneous auricular 
vagus nerve stimulation (taVNS) 
via electrical stimulation of the 
tragus: A concurrent taVNS/fMRI 
study and review. Brain Stimulation. 
2018;11(3):492-500
[56] Koopman FA, Schuurman PR, 
Vervoordeldonk MJ, Tak PP. Vagus 
nerve stimulation: A new bioelectronics 
approach to treat rheumatoid arthritis. 
Best Practice & Research. Clinical 
Rheumatology. 2014;28:625-635
[57] Addorisio ME et al. Investigational 
treatment of rheumatoid arthritis with 
a vibrotactile device applied to the 
external ear. Bioelectronic Medicine. 
2019;5(4)
[58] Narayanan JT, Watts R, Haddad N, 
Labar DR, Li MP, Filippi CG. Cerebral 
activation during vagus nerve 
stimulation: A functional MR study. 
Epilepsia. 2002;43(12):1509-1514
[59] Sclocco R et al. Stimulus frequency 
modulates brainstem response to 
respiratory-gated transcutaneous 
auricular vagus nerve stimulation. Brain 
Stimulation. 2020;13:970-978
[60] Chiu IM, von Hehn CA, Woolf CJ.  
Neurogenic inflammation - the 
peripheral nervous system’s role in host 
defense and immunopathology. Nature 
Neuroscience. 2013;15(8):1063-1067
[61] O’Connell NE, Wand BM, 
Marston L, Spencer S, Desouza LH. Non-
invasive brain stimulation techniques 
for chronic pain. Cochrane Database of 
Systematic Reviews. 2014;4:CD008204
[62] Wrigley PJ, Gustin SM, McIndoe LN, 
Chakiath RJ, Henderson LA, Siddall PJ. 
Longstanding neuropathic pain after 
spinal cord injury is refractory to 
transcranial direct current stimulation: 
A randomized controlled trial. Pain. 
2013;15:2178-2184
[63] Ahn H et al. Efficacy of transcranial 
direct current stimulation over primary 
motor cortex (anode) and contralateral 
supraorbital area (cathode) on clinical 
pain severity and mobility performance 
in persons with knee osteoarthritis: 
An experimenter- and participant - 
blinded randomized, sham-controlled 
pilot clinical study. Brain Stimulation. 
2017;10:902-909
[64] Khedr EM et al. Effects of 
transcranial direct current stimulation 
on pain, mood and serum endorphin 
level in the treatment of fibromyalgia: 
A double blinded, randomized clinical 
trial. Brain Stimulation. 2017;10:893-901
[65] Ayache SS et al. Prefrontal tDCS 
decreases pain in patients with multiple 
sclerosis. Frontiers in Neuroscience. 
2016;10:147
[66] Borckardt JJ et al. Prefrontal versus 
motor cortex transcranial direct current 
stimulation (tDCS) effects on post-
surgical opioid use. Brain Stimulation. 
2017;10(6):1096-1101
[67] Caravaca AS et al. An effective 
method for acute vagus nerve 
stimulation in experimental 
inflammation. Frontiers in 
Neuroscience. 2019;13:877
[68] Charvet LE, Shaw MT, Bikson M, 
Woods AJ, Knotkova H. Supervised 
transcranial direct current stimulation 
(tDCS) at home: A guide for 
clinical research and practice. Brain 
Stimulation. 2020;13:686-693
[69] Peterchev AV et al. Fundamentals 
of transcranial electric and magnetic 
stimulation dose: Definition, selection 
and reporting practices. Brain 
Stimulation. 2012;5(4):435-453
Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice
16
[70] Nitsche MA, Liebetanz D, Antal A, 
Lang N, Tergau F, Paulus W. Modulation 
of cortical excitability by weak direct 
durrent stimulation - technical, safety 
and functional aspects. Supplements 
to Clinical Neurophysiology. 
2003;56:255-276
[71] Nitsche MA et al. Shaping the 
effects of transcranial direct current 
stimulation of the human motor 
cortex. Journal of Neurophysiology. 
2007;97:3109-3117
[72] Mikkonen M, Laakso I, Tanaka S,  
Hirata A. Cost of focality in TDCS: 
Interindividual variability in electric 
fields. Brain Stimulation. 2020;13:117-124
[73] Datta A, Truong D, Minhas P, 
Parra LC, Bikson M. Inter-individual 
variation during transcranial direct 
current stimulation and normalisation 
of dose using MRI-derived 
computational models. Frontiers in 
Psychiatry. 2012;3(91):1-8
[74] Unal G et al. Impact of brain 
atrophy on tDCS and HD-tDCS 
current flow: A modeeling study in 
three variants of primary progressive 
aphasia. Neurological Sciences. 
2020;41:1781-1789
[75] Evans C, Bachmann C, Lee JSA, 
Gregoriou E, Ward N. Dose-controlled 
tDCS reduces electric field intensity 
variability at a cortical target site. Brain 
Stimulation. 2020;13(1):125-136
[76] Caulfield KA et al. Transcranial 
electrical stimulation motor threshold 
can estimate individualised tDCS 
dosage from reverse calculation electric-
field modeling. Brain Stimulation. 
2020;13:961-969
[77] Datta A, Bansal V, Diaz J, Patel J, 
Reato D, Bikson M. Gyri-precise head 
model of transcranial direct current 
stimulation: Improved spatial 
focality using a ring electrode versus 
conventional rectangular pad. Brain 
Stimulation. 2009;2:201-207
[78] Kuo H-I et al. Comparing cortical 
plasticity induced by conventional 
and high definition 4X1 ring tDCS: 
A neurophysiological study. Brain 
Stimulation. 2013;6:644-648
[79] Bindman LJ, Lippold OC, 
Redfearn JW. The action of brief 
polarizing currents on the cerebral 
cortex of the rat (1) during current flow 
and (2) in the production of long-lasting 
after-effects. Journal of Physiology. 
1964;172:369-382
[80] Bikson M, Lian J, Hahn PJ, 
Stacey WC, Sciortino C, Durand DM. 
Suppression of epileptiform activity 
by high frequency sinusoidal fields 
in rat hippocampal slices. Journal of 
Physiology. 2001;531(1):181-191
[81] Khadka N et al. Adaptive current 
tDCS up to 4mA. Brain Stimulation. 
2020;13:69-79
[82] Jamil A et al. Systematic evaluation 
of the impact of stimulation intensity 
on neuroplastic after-effects induced 
by transcranial direct current 
stimulation. Journal of Physiology. 
2017;595(4):1273-1288
[83] Esmaeilpour Z et al. Incomplete 
evidence that increasing current 
intensity of tDCS boosts outcomes. 
Brain Stimulation. 2018;11(2):310-321
[84] Samani MM, Agboada D, Kuo M-F, 
Nitsche MA. Probing the relevance of 
repeated cathodal transcranial direct 
current stimulation over the primary 
motor cortex for prolongation of 
after-effects. Journal of Physiology. 
2020;598(4):805-816
[85] McLaren ME, Nissim NR, 
Woods AJ. The effects of medication 
use in transcranial direct current 
stimulation: A brief review. Brain 
Stimulation. 2018;11:52-58
17
From Mechanisms to Analgesia: Towards the Use of Non-Invasive Neuromodulation for Pain…
DOI: http://dx.doi.org/10.5772/intechopen.93277
[86] Chung SW, et al. The influence of 
endogenous estrogen on high-frequency 
prefrontal transcranial magnetic 
stimulation. Brain Stimulation. 
2019;12(5):1271-1279
[87] Galea JM, Jayaram G, Ajagbe L, 
Celnik P. Modulation of cerebellar 
excitability by polarity-specific 
noninvasive direct current 
stimulation. Journal of Neuroscience. 
2009;29:9115-9122
[88] Nitsche MA et al. Transcranial 
direct current stimulation: State 
of the art 2008. Brain Stimulation. 
2008;1:206-223
[89] Pelletier SJ, Cicchetti F. Cellular 
and molecular mechanisms of 
action of transcranial direct current 
stimulation: Evidence from in vitro 
and in vivo models. International 
Journal of Neuropsychopharmacology. 
2015;18(2):1-13
[90] Nitsche M, Liebetanz D, Lang N, 
Antal A, Tergau F, Paulus W. Safety 
criteria for transcranial direct current 
stimulation (tDCS) in humans. Clinical 
Neurophysiology. 2003;114:2220-2222
[91] Stagg CJ et al. Polarity 
sensitive modulation of cortical 
neurotransmitters by transcranial 
stimulation. Journal of Neuroscience. 
2009;29:5202-5206
[92] Kronberg G, Bridi M, Abel T, 
Bikson M, Parra LC. Direct current 
stimulation modulates LTP and 
LTD: Activity dependence and 
dendritic effects. Brain Stimulation. 
2017;10:51-57
[93] Kronberg G, Rahman A, 
Sharma M, Bikson M, Parra LC. Direct 
current stimulation boosts hebbian 
plasticity in vitro. Brain Stimulation. 
2020;13:287-301
[94] Turrigiano G. Too many cooks? 
Intrinsic and synaptic homeostatic 
mechanisms in cortical circuit 
refinement. Annual Review of 
Neuroscience. 2011;34:89-103
[95] Bienenstock EL, Cooper LN, 
Munro PW. Theory for the development 
of neuron selectivity: Orientation 
specificity and binocular interaction 
in visual cortex. The Journal of 
Neuroscience. 1982;2(1):32-48
[96] Bikson M et al. Effects of uniform 
extracellular DC electric fields on 
excitability in rat hippocampal slices in 
vitro. Journal of Physiology (London). 
2004;557:175-190
[97] Kabakov AY, Muller PA, 
Pascual-Leone A, Jensen FE, 
Rotenberg A. Contribution of axonal 
orientation to pathway-dependent 
modulation of excitatory transmission 
by direct current stimulation in 
isolated rat hippocampus. Journal of 
Neurophysiology. 2012;107:1881-1889
[98] Lin RL, Douaud G, Filippini N, 
Okell TW, Stagg CJ, Tracey I. Structural 
connectivity variances underlie 
functional and behavioural changes 
during pain relief induced by 
neuromodulation. Scientific Reports. 
2017;7:41603
[99] Shahid SS, Bikson M, Salman H, 
Wen P, Ahfock T. The value and cost of 
complexity in predictive modelling: Role 
of tissue anisotropic conductivity and 
fibre tracts in neuromodulation. Journal 
of Neural Engineering. 2014;11:036003
[100] Clancy JA, Johnson R, Raw R, 
Deuchars SA, Deuchars J. Transcranial 
direct current stimulation (tDCS)/
Transcranial alternating current 
stimulation (tACS): Anodal 
Transcranial direct current stimulation 
(tDCS) over the motor cortex increases 
sympathetic nerve activity. Brain 
Stimulation. 2014;7:97-104
[101] Hohn VD, May ES, Ploner M. 
From correlation towards causality: 
Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice
18
Modulating brain rhythms using 
transcranial alternating current 
stimulation. PAIN Reports. 2019;4:e723
[102] Prim JH, Ahn S, Alexander ML, 
McCulloch KL, Frohlich F. Targeting 
the autonomic nervous system balance 
in patients with chronic low back pain 
using transcranial alternating current 
stimulation: A randomized, crossover 
double-blind, placebo-controlled 
pilot study. Journal of Pain Research. 
2019;12:3265-3277
[103] Asamoah B, Khatoun A, 
McLaughlin M. tACS motor system 
effects can be caused by transcutaneous 
stimulation of peripheral nerves. Nature 
Communications. 2019;10(1):1-16
[104] Ruohonen J, Karhu J. tDCS 
possibly stimulates glial cells. Clinical 
Neurophysiology. 2012;123:2006-2009
[105] Cioato SG et al. Long-lasting 
effect of transcranial direct current 
stimulation in the reversal of 
hyperalgesia and cytokine alterations 
induced by the neuropathic pain model. 
Brain Stimulation. 2016;9(2):209-217
[106] Lopes BC et al. Transcranial direct 
current stimulation combined with 
exercise modulates the inflammatory 
profile and hyperalgesic response in rats 
subjected to a neuropathic pain model: 
Long term effects. Brain Stimulation. 
2020;13:774-782
